top of page

Fleet Maintain Operations Under Latest UK Government Covid-19 Guidance

Updated: Jan 13

Although wherever possible our staff are now working from home, we are maintaining our laboratory development and production activities. Many of our customers rely on our conjugates to support essential in vitro diagnostic (IVD) products used throughout the world, and we are determined to maintain supply of these.

We have also been approached for support by two separate consortia developing novel Covid-19 immunoassays, and of course we will make this work a priority if we are brought on board.

Please contact us if you have any concerns over product supply from Fleet during these difficult times.

Recent Posts

See All

Recently, one of Fleet Bioprocessing’s experts was asked to consult on a project. Nothing unusual about that, Fleet experts regularly act as consultants for clients advising on bioconjugation, ELISA a

At Fleet Bioprocessing Ltd., we take pride in being a Gyrolab Certified Assay Transfer and Development Partner. Fleet Bioprocessing Ltd. enjoys global recognition for our proficiency in bioconjugation

bottom of page